|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-0.11/-0.11
|
Enterprise Value
46.96M
|
Balance Sheet |
Book Value Per Share
0.06
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
1.10M
|
Operating Revenue Per Share
0.01
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/05/16 07:05 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. |